Chemical Structure (Sevelamer 01)
Sevelamer Carbonate Powder, For Suspension
Product Images NDC 0955-1052
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 0955-1052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Sevelamer 02)
Figure 3 (Sevelamer 03)
Figure 4 (Sevelamer 04)
Principal Display Panel (800 mg Bottle Label)
This is a description for a medication called Sevelamer Carbonate Tablets, 800 mg. It contains certain active ingredients and inactive components. It is advised to store the medication in a tight container at a temperature of 25°C and to protect it from moisture. The packaging has the NDC number 0955-1050-27 and is only available with a prescription. The recommended dosage is given in the package insert. The medication is manufactured for Winthrop U.S., a business of Sanofi-aventis US, LLC. There are 270 film-coated tablets in the package. The text includes the GTIN number 0030551050275 and the DOM identifier.*
Principal Display Panel (0.8 g Packet Box)
This is a medical product related text that provides information about Sevelamer Carbonate that is manufactured by Winthrop and is available as an oral suspension in packets containing 90 sachets. The brand name of the medication is Sanofi, and the text includes some additional details such as the dosage of the medication.*
Principal Display Panel (2.4 g Packet Box)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
